Copyright
©The Author(s) 2023.
World J Meta-Anal. Sep 18, 2023; 11(6): 266-276
Published online Sep 18, 2023. doi: 10.13105/wjma.v11.i6.266
Published online Sep 18, 2023. doi: 10.13105/wjma.v11.i6.266
Table 1 Various therapeutic agents used for the treatment of coronavirus disease 2019
| Sr. No. | Therapeutic agents | Examples |
| 1 | Antiviral agents | 1 Remdesivir |
| 2 Favipiravir | ||
| 3 Ribavirin | ||
| 4 Interferons | ||
| 5 Ritonavir/Lopinavir | ||
| 6 Arbidol | ||
| 7 Chloroquine/Hydroxychloroquine | ||
| 8 Recombinant soluble ACE2 | ||
| 9 Azithromycin | ||
| 10 Ivermectin | ||
| 11 Nitazoxanide | ||
| 12 Camostat mesylate | ||
| 13 Paxlovid | ||
| 2 | Biologic agents | 1 Monoclonal antibodies |
| 2 Convalescent plasma | ||
| 3 Hyperimmune sera | ||
| 4 Exogenous surfactant delivery | ||
| 3 | Anti-inflammatory agents | 1 Corticosteroids |
| 2 Fluvoxamine | ||
| 3 Anakinra | ||
| 4 Granulocyte-macrophage colony-stimulating factor inhibitors | ||
| 5 Intravenous immunoglobulin | ||
| 6 Janus kinase inhibitors | ||
| 7 Colchicine | ||
| 4 | Herbal agents | Various Chinese herbal medicine |
| 5 | Preventive agents | Vaccines |
- Citation: Mokhria RK, Bhardwaj JK, Sanghi AK. History, origin, transmission, genome structure, replication, epidemiology, pathogenesis, clinical features, diagnosis, and treatment of COVID-19: A review. World J Meta-Anal 2023; 11(6): 266-276
- URL: https://www.wjgnet.com/2308-3840/full/v11/i6/266.htm
- DOI: https://dx.doi.org/10.13105/wjma.v11.i6.266